Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M503Revenue $M0.8Net Margin (%)-2,456.1Z-Score12.5
Enterprise Value $M457EPS $-0.7Operating Margin %-3,213.6F-Score3
P/E(ttm))0Cash Flow Per Share $-0.7Pre-tax Margin (%)-2,456.1Higher ROA y-yN
Price/Book13.610-y EBITDA Growth Rate %14.0Quick Ratio4.1Cash flow > EarningsN
Price/Sales4905-y EBITDA Growth Rate %15.1Current Ratio4.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-56.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-89.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M103ROI % (ttm)-167.5Gross Margin Increase y-yN

Gurus Latest Trades with ZIOP

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZIOPJean-Marie Eveillard 2013-06-30 Sold Out $1.52 - $2.621
($1.85)
$ 4.9165%Sold Out0
ZIOPJean-Marie Eveillard 2013-03-31 Buy $1.72 - $5.71
($4.42)
$ 4.911%New holding, 200000 sh.200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZIOP is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ZIOP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIRK RANDAL JDirector, 10% Owner 2013-10-29Buy2,857,143$3.540view
KIRK RANDAL JDirector, 10% Owner 2012-01-20Buy1,923,075$5.2-5.77view
KIRK RANDAL JDirector, 10% Owner 2011-08-23Buy38,294$4.99-1.8view
KIRK RANDAL JDirector, 10% Owner 2011-08-22Buy461,646$4.92-0.41view
Fowler WycheDirector 2011-08-10Buy5,000$5.19-5.59view
KIRK RANDAL JDirector, 10% Owner 2011-08-09Buy846,522$4.782.51view
WEISER MICHAELDirector 2011-05-25Sell15,000$6.53-24.96view
BRENNAN MURRAYDirector 2011-05-09Sell15,000$6.57-25.42view
KIRK RANDAL JDirector, 10% Owner 2011-02-03Buy1,910,000$5.75-14.78view
MCINERNEY TIMOTHYDirector 2009-12-09Buy50,000$3.158.06view

Press Releases about ZIOP :

    Quarterly/Annual Reports about ZIOP:

    News about ZIOP:

    Articles On GuruFocus.com
    Hayman Advisors Update - Second Quarter Sells and Company Results Aug 26 2013 
    Bass’ New Buy – ZIOPHARM Oncology Inc. May 16 2013 
    The Far-Off Four, 52-week Lows Held by Gurus May 11 2013 
    comment on ZIOP Mar 15 2013 
    cooldecency99 note on ZIOP May 01 2010 
    ZIOPHARM Reports Second Quarter Financial Results and Updates Clinical Programs Aug 14 2009 

    More From Other Websites
    ZIOPHARM and Intrexon Present Clinical and Preclinical Data From Immuno-Oncology Programs at AACR... Dec 03 2014
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Dec 03 2014
    ZIOPHARM and Intrexon Present Clinical and Preclinical Data From Immuno-Oncology Programs at AACR... Dec 03 2014
    ZIOPHARM and Intrexon Present Clinical and Preclinical Data From Immuno-Oncology Programs at AACR... Dec 03 2014
    Increased Earnings Estimates Seen for ZIOPHARM Oncology (ZIOP): Can It Move Higher? Dec 03 2014
    10-Q for ZIOPHARM Oncology, Inc. Nov 01 2014
    Ziopharm posts 3Q loss Oct 31 2014
    Ziopharm posts 3Q loss Oct 31 2014
    ZIOPHARM Reports Third-Quarter 2014 Financial Results Oct 30 2014
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Oct 30 2014
    ZIOPHARM Reports Third-Quarter 2014 Financial Results Oct 30 2014
    ZIOPHARM ONCOLOGY INC Files SEC form 10-Q, Quarterly Report Oct 30 2014
    Mid-Afternoon Market Update: Dow Rises Over 150 Points; Kohl's Shares Decline On Weak Forecast Oct 28 2014
    ZIOPHARM Oncology (ZIOP) Jumps: Stock Moves Up 8.5% Oct 24 2014
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Unregistered Sale of Equity Securities Sep 16 2014
    ZIOPHARM Oncology (ZIOP) in Focus: Stock Rises 10.4% Sep 08 2014
    ZIOPHARM ONCOLOGY INC Financials Aug 15 2014
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 07 2014
    ZIOPHARM ONCOLOGY INC Files SEC form 10-Q, Quarterly Report Aug 07 2014
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 31 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK